ResearcherEmory UniversityActive in the last 2 years
Parit Mekaroonkamol
Matched on ORCID iD 0000-0002-3206-3431; OpenAlex author ID A5043479602. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: 3 papers
Papers 5
- One-year survival rate of unresectable pancreatic cancer size 4 cm or smaller treated with or without EUS-radiofrequency ablation. Co-author DOI 10.1016/j.gie.2025.06.008↗
- Portal versus peripheral circulating tumor cells as prognostic biomarkers in patients with stage I-III pancreatic ductal adenocarcinoma. Co-author DOI 10.1055/a-2535-7440↗
- Correction: Portal versus peripheral circulating tumor cells as prognostic biomarkers in patients with stage I-III pancreatic ductal adenocarcinoma. Co-author DOI 10.1055/a-2571-2951↗
- Application of artificial intelligence for diagnosis of pancreatic ductal adenocarcinoma by EUS: A systematic review and meta-analysis. Co-author DOI 10.4103/eus-d-20-00219↗
- Endoscopic management of pain in pancreatic cancer. Co-author DOI 10.6092/1590-8577/2890↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Pradermchai Kongkam · 4 shared papers, 2022–2025 · strength 0.87
- Paper Portal versus peripheral circulating tumor cells as prognostic biomarkers in patients with stage I-III pancreatic ducta… DOI 10.1055/a-2535-7440↗
- Paper Correction: Portal versus peripheral circulating tumor cells as prognostic biomarkers in patients with stage I-III panc… DOI 10.1055/a-2571-2951↗
- Paper One-year survival rate of unresectable pancreatic cancer size 4 cm or smaller treated with or without EUS-radiofrequenc… DOI 10.1016/j.gie.2025.06.008↗
- Rungsun Rerknimitr · 4 shared papers, 2022–2025 · strength 0.87
- Paper Portal versus peripheral circulating tumor cells as prognostic biomarkers in patients with stage I-III pancreatic ducta… DOI 10.1055/a-2535-7440↗
- Paper Correction: Portal versus peripheral circulating tumor cells as prognostic biomarkers in patients with stage I-III panc… DOI 10.1055/a-2571-2951↗
- Paper One-year survival rate of unresectable pancreatic cancer size 4 cm or smaller treated with or without EUS-radiofrequenc… DOI 10.1016/j.gie.2025.06.008↗
- Phonthep Angsuwatcharakon · 3 shared papers, 2025 · strength 0.70
- Paper Portal versus peripheral circulating tumor cells as prognostic biomarkers in patients with stage I-III pancreatic ducta… DOI 10.1055/a-2535-7440↗
- Paper Correction: Portal versus peripheral circulating tumor cells as prognostic biomarkers in patients with stage I-III panc… DOI 10.1055/a-2571-2951↗
- Paper One-year survival rate of unresectable pancreatic cancer size 4 cm or smaller treated with or without EUS-radiofrequenc… DOI 10.1016/j.gie.2025.06.008↗
- Thaninee Prasoppokakorn · 3 shared papers, 2022–2025 · strength 0.66
- Paper Portal versus peripheral circulating tumor cells as prognostic biomarkers in patients with stage I-III pancreatic ducta… DOI 10.1055/a-2535-7440↗
- Paper Correction: Portal versus peripheral circulating tumor cells as prognostic biomarkers in patients with stage I-III panc… DOI 10.1055/a-2571-2951↗
- Paper Application of artificial intelligence for diagnosis of pancreatic ductal adenocarcinoma by EUS: A systematic review an… DOI 10.4103/eus-d-20-00219↗
- Roongruedee Chaiteerakij · 3 shared papers, 2022–2025 · strength 0.66
- Paper Portal versus peripheral circulating tumor cells as prognostic biomarkers in patients with stage I-III pancreatic ducta… DOI 10.1055/a-2535-7440↗
- Paper Correction: Portal versus peripheral circulating tumor cells as prognostic biomarkers in patients with stage I-III panc… DOI 10.1055/a-2571-2951↗
- Paper Application of artificial intelligence for diagnosis of pancreatic ductal adenocarcinoma by EUS: A systematic review an… DOI 10.4103/eus-d-20-00219↗
- Nipan Israsena · 2 shared papers, 2025 · strength 0.49
- Paper Portal versus peripheral circulating tumor cells as prognostic biomarkers in patients with stage I-III pancreatic ducta… DOI 10.1055/a-2535-7440↗
- Paper Correction: Portal versus peripheral circulating tumor cells as prognostic biomarkers in patients with stage I-III panc… DOI 10.1055/a-2571-2951↗
- Pinit Kullavanijaya · 1 shared paper, 2025 · strength 0.21
- Kasenee Tiankanon · 1 shared paper, 2025 · strength 0.21
- Thanawat Luangsukrerk · 1 shared paper, 2025 · strength 0.21
- Saurabh Chawla · 1 shared paper, 2015 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.